RaySearch Laboratories AB (publ)
RAY-B.STRaySearch Laboratories AB (publ) in brief
RaySearch Laboratories AB (publ) is a listed company in the Healthcare Information Services industry, based in Sweden. Its last known market value was $300 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $137 M and a net profit of $23 M, about 17 cents of profit for every dollar of sales. Its shares trade under the symbol RAY-B.ST (Stockholm).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
RaySearch Laboratories AB (publ) timeline
- 1988
- 🏁· approximateIncorporated as RaySearch Laboratories AB (publ)
- 2017
- •Legal Entity Identifier issuedLEI 549300TYFVYGS0JFWM28 registered.
Events of RaySearch Laboratories AB (publ) from the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Sweden: #179 (Jan 2020) · #216 (Jan 2021) · #291 (Jan 2022) · #234 (Dec 2022) · #223 (Jul 2023) · #204 (Jan 2024)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 16.9%
- Operating margin
- 21.7%
- Return on equity
- 21.7%
- Liabilities / assets
- 50.5%
- Revenue growth
- +21.3%
- R&D / revenue
- 20.1%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $137M | +21.3% | $30M | $23M | 16.9% |
| Dec 2024 | $113M | — | $25M | $19M | 17.1% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $39M | $3M | $37M | $0.68 | — |
| Dec 2024 | $46M | $1M | $45M | $0.56 | — |
Annual results
- Revenue
- $137 M
- Operating income
- $30 M
- Net income
- $23 M
For year ending December-2025 · source: official annual report (ESEF)
Balance sheet
- Total assets
- $216 M
- Total liabilities
- $109 M
- Total equity
- $107 M
As of December-2025
Mutual funds holding RaySearch Laboratories AB (publ)#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇸🇪 Swedbank Robur Småbolagsfond SverigeSwedbank Robur Fonder AB | 961,850 | $22 M | — | 0.80% | no change | Jun 30, 2026 |
| 🇸🇪 Case All Star SmåbolagCase Kapitalförvaltning AB | 844,154 | $19 M | — | 5.7% | −5.6% | Jun 30, 2026 |
| 🇺🇸 Avantis International Small Cap Value ETFAmerican Century ETF Trust | 552,413 | $13 M | — | 0.07% | +16% | May 31, 2026 |
| 🇸🇪 Swedbank Robur Ny TeknikSwedbank Robur Fonder AB | 558,183 | $13 M | — | 1.1% | −14% | Jun 30, 2026 |
| 🇸🇪 Handelsbanken Svenska SmåbolagHandelsbanken Fonder AB | 475,000 | $11 M | — | 0.74% | +116% | Jun 30, 2026 |
| 🇸🇪 Swedbank Robur ExportfondSwedbank Robur Fonder AB | 420,000 | $9 M | — | 0.84% | +45% | Jun 30, 2026 |
| 🇸🇪 Humle SmåbolagsfondAtle Fund Management AB | 300,000 | $7 M | — | 1.2% | +72% | Jun 30, 2026 |
| 🇸🇪 Handelsbanken Sverige Index CriteriaHandelsbanken Fonder AB | 273,037 | $6 M | — | 0.07% | +6.1% | Jun 30, 2026 |
| 🇸🇪 Swedbank Robur HealthcareSwedbank Robur Fonder AB | 233,682 | $5 M | — | 0.35% | −7.6% | Jun 30, 2026 |
| 🇸🇪 TIN Ny TeknikTeknik Innovation Norden Fonder AB | 220,000 | $5 M | — | 3.5% | no change | Jun 30, 2026 |
| 🇸🇪 AMF Aktiefond SmåbolagAMF Fonder AB | 200,000 | $5 M | — | 0.34% | new | Jun 30, 2026 |
| 🇸🇪 FE Småbolag SverigeFCG Fonder AB | 193,527 | $4 M | — | 1.3% | new | Jun 30, 2026 |
| 🇸🇪 Lannebo Hälsa och Ny TeknikLannebo Kapitalförvaltning AB | 191,638 | $4 M | — | 7.1% | +73% | Jun 30, 2026 |
| 🇸🇪 SEB Sverige IndexnäraSEB Funds AB | 153,942 | $3 M | — | 0.05% | +4.9% | Jun 30, 2026 |
| 🇸🇪 Handelsbanken Norden Index CriteriaHandelsbanken Fonder AB | 146,072 | $3 M | — | 0.09% | +39% | Jun 30, 2026 |
| 🇺🇸 iShares Core MSCI EAFE ETFBlackRock Fund Advisors | 171,044 | $3 M | — | <0.01% | +1.2% | Jul 31, 2026 |
| 🇺🇸 The Continental Small Company SeriesDimensional Fund Advisors LP | 160,951 | $3 M | — | 0.04% | −0.6% | Jul 31, 2026 |
| 🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP | 131,837 | $2 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust | 96,704 | $2 M | — | 0.01% | +6.7% | May 31, 2026 |
| 🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP | 108,001 | $2 M | — | 0.04% | +0.7% | Jul 31, 2026 |
| 🇺🇸 iShares MSCI EAFE Small-Cap ETFBlackRock Fund Advisors | 103,993 | $2 M | — | 0.01% | −9.8% | Jul 31, 2026 |
| 🇸🇪 Skandia Småbolag SverigeSkandia Fonder AB | 82,457 | $2 M | — | 0.51% | new | Jun 30, 2026 |
| 🇸🇪 Skandia Sverige ExponeringSkandia Fonder AB | 79,617 | $2 M | — | 0.10% | no change | Jun 30, 2026 |
| 🇸🇪 Aktiespararna Småbolag EdgeCicero Fonder AB | 75,000 | $2 M | — | 2.3% | no change | Jun 30, 2026 |
| 🇸🇪 SEB Sverige IndexfondSEB Funds AB | 68,695 | $2 M | — | 0.05% | +14% | Jun 30, 2026 |
| 🇸🇪 Storebrand Sverige PlusStorebrand Asset Management AS | 68,000 | $2 M | — | 0.07% | +11% | Jun 30, 2026 |
| 🇸🇪 Lysa Sweden Equity FocusLysa Fonder AB | 50,003 | $1 M | — | 0.69% | +4.9% | Jun 30, 2026 |
| 🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP | 51,691 | $1 M | — | <0.01% | −6.6% | Jul 31, 2026 |
| 🇸🇪 Storebrand Sverige Småbolag PlusStorebrand Asset Management AS | 32,500 | $1 M | — | 0.21% | +1.6% | Jun 30, 2026 |
| 🇺🇸 William Blair International Small Cap Growth FundWilliam Blair Investment Management, LLC | 31,650 | $1 M | — | 0.52% | −2.3% | Jun 30, 2026 |
| 🇸🇪 Lysa Sweden Equity BroadLysa Fonder AB | 26,280 | $1 M | — | 0.08% | +11% | Jun 30, 2026 |
| 🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc. | 25,001 | $1 M | — | 0.07% | +1.0% | Jun 30, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 23,387 | $1 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇸🇪 XACT SVENSKA SMÅBOLAG (UCITS ETF)Handelsbanken Fonder AB | 22,260 | $1 M | — | 0.26% | +11% | Jun 30, 2026 |
| 🇺🇸 Avantis International Small Cap Value FundAmerican Century ETF Trust | 20,163 | $0 M | — | 0.07% | −30% | May 31, 2026 |
| 🇺🇸 International Vector Equity PortfolioDimensional Fund Advisors LP | 24,827 | $0 M | — | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 WisdomTree International SmallCap Dividend FundWisdomTree Asset Management, Inc. | 20,311 | $0 M | — | 0.04% | +1.2% | Jun 30, 2026 |
| 🇸🇪 Lannebo Teknik SmåbolagLannebo Kapitalförvaltning AB | 21,900 | $0 M | — | 1.5% | — | Mar 31, 2026 |
| 🇺🇸 iShares Core MSCI Europe ETFBlackRock Fund Advisors | 22,966 | $0 M | — | <0.01% | −2.2% | Jul 31, 2026 |
| 🇺🇸 Dimensional International Core Equity Market ETFDimensional Fund Advisors LP | 22,496 | $0 M | — | <0.01% | +7.5% | Jul 31, 2026 |
| 🇺🇸 iShares International Small-Cap Equity Factor ETFBlackRock Fund Advisors | 21,018 | $0 M | — | 0.06% | −48% | Jul 31, 2026 |
| 🇸🇪 Skandia BalanseradSkandia Fonder AB | 16,502 | $0 M | — | 0.02% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC | 17,340 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 16,035 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 International Sustainability Core 1 PortfolioDimensional Fund Advisors LP | 14,641 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇸🇪 Aktiespararna AktivCicero Fonder AB | 11,146 | $0 M | — | 1.7% | −14% | Jun 30, 2026 |
| 🇸🇪 Skandia Världen SverigeSkandia Fonder AB | 11,096 | $0 M | — | 0.03% | no change | Jun 30, 2026 |
| 🇺🇸 WisdomTree Dynamic International Equity FundWisdomTree Asset Management, Inc. | 10,785 | $0 M | — | 0.02% | +58% | Jun 30, 2026 |
| 🇸🇪 Handelsbanken Global Småbolag Index CriteriaHandelsbanken Fonder AB | 10,678 | $0 M | — | 0% | +67% | Jun 30, 2026 |
| 🇸🇪 PLUS Småbolag Sverige IndexISEC Services AB | 10,579 | $0 M | — | 0.20% | −0.7% | Jun 30, 2026 |
| 🇸🇪 PLUS Allabolag Sverige IndexISEC Services AB | 10,328 | $0 M | — | 0.05% | +1.0% | Jun 30, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 10,869 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇸🇪 Lannebo Marknad Sverige BredLannebo Kapitalförvaltning AB | 8,900 | $0 M | — | 0.04% | −29% | Jun 30, 2026 |
| 🇸🇪 Nordnet Småbolag Sverige IndexNordnet Fonder AB | 8,558 | $0 M | — | 0.39% | −13% | Jun 30, 2026 |
| 🇺🇸 WisdomTree Dynamic International SmallCap Equity FundWisdomTree Asset Management, Inc. | 8,457 | $0 M | — | 0.05% | −5.6% | Jun 30, 2026 |
| 🇺🇸 State Street SPDR Portfolio MSCI Global Stock Market ETFSSGA Funds Management, Inc. | 8,368 | $0 M | — | 0.01% | +266% | Jun 30, 2026 |
| 🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc. | 8,022 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇸🇪 Cicero SverigeCicero Fonder AB | 8,068 | $0 M | — | 0.84% | no change | Jun 30, 2026 |
| 🇺🇸 Brighthouse/Dimensional International Small Company PortfolioBrighthouse Investment Advisers, LLC | 7,299 | $0 M | — | 0.04% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity SAI International Small Cap Index FundFidelity Management & Research Company LLC | 8,133 | $0 M | — | 0.01% | −5.5% | Jul 31, 2026 |
| 🇺🇸 Dimensional International Sustainability Core 1 ETFDimensional Fund Advisors LP | 8,007 | $0 M | — | 0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 International Small Cap Growth PortfolioDimensional Fund Advisors LP | 7,143 | $0 M | — | 0.04% | no change | Jul 31, 2026 |
| 🇺🇸 WisdomTree Europe SmallCap Dividend FundWisdomTree Asset Management, Inc. | 5,529 | $0 M | — | 0.08% | no change | Jun 30, 2026 |
| 🇺🇸 International Social Core Equity PortfolioDimensional Fund Advisors LP | 6,360 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇸🇪 Kvartil Nordiska Småbolag+ FaktorQuartile Fonder AB | 4,872 | $0 M | — | 0.34% | +137% | Jun 30, 2026 |
| 🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust | 4,329 | $0 M | — | 0.03% | +18% | May 31, 2026 |
| 🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP | 5,421 | $0 M | — | 0.02% | no change | Jul 31, 2026 |
| 🇸🇪 Småbolag Sverige ExponeringSkandia Fonder AB | 4,120 | $0 M | — | 0.24% | +14% | Jun 30, 2026 |
| 🇺🇸 WisdomTree International Equity FundWisdomTree Asset Management, Inc. | 3,577 | $0 M | — | 0.01% | −1.6% | Jun 30, 2026 |
| 🇺🇸 Avantis International Equity FundAmerican Century ETF Trust | 3,339 | $0 M | — | <0.01% | +32% | May 31, 2026 |
| 🇺🇸 Avantis Responsible International Equity ETFAmerican Century ETF Trust | 2,885 | $0 M | — | 0.01% | +0.9% | May 31, 2026 |
| 🇺🇸 iShares MSCI Europe Small-Cap ETFBlackRock Fund Advisors | 3,216 | $0 M | — | 0.03% | −3.8% | Jul 31, 2026 |
| 🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC | 2,452 | $0 M | — | 0.05% | no change | Jun 30, 2026 |
| 🇺🇸 LVIP Dimensional International Core Equity FundLincoln Financial Investments Corporation | 2,208 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇸🇪 Avanza SwedenAvanza Fonder AB | 1,841 | $0 M | — | 0.08% | — | Jun 30, 2026 |
| 🇺🇸 iShares MSCI World Small-Cap ETFBlackRock Fund Advisors | 1,742 | $0 M | — | <0.01% | −24% | May 31, 2026 |
| 🇸🇪 Skandia FörsiktigSkandia Fonder AB | 1,573 | $0 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Parametric International Equity FundEaton Vance Management | 1,617 | $0 M | — | 0.01% | new | Jul 31, 2026 |
| 🇺🇸 AZL DFA International Core Equity FundAllianz Investment Management LLC | 1,213 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇸🇪 Skandia Mix 60 ExponeringSkandia Fonder AB | 1,140 | $0 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇸🇪 Skandia Mix 100 ExponeringSkandia Fonder AB | 1,082 | $0 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 State Street SPDR Portfolio Europe ETFSSGA Funds Management, Inc. | 1,063 | $0 M | — | <0.01% | −2.2% | Jun 30, 2026 |
| 🇺🇸 Dimensional International Vector Equity ETFDimensional Fund Advisors LP | 839 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 83 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
RaySearch Laboratories AB (publ) scorecard#
Passes 5 of the 5 checks that could be worked out. Fiscal year 2025.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth2 of 2
- ✓Revenue grew in the newest year21.3%Revenue up 21.3% in fiscal 2025.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✓Earnings per share grew in the newest year0.68 vs 0.56Diluted EPS 0.68 in fiscal 2025 against 0.56 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability3 of 3
- ✓Profitable in the newest year$23 MNet income $23 M in fiscal 2025.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- ✓Operating margin above its peers' median21.7%21.7% against Healthcare Information Services's median of -7.1% (29 companies).
- ✓Return on equity above 15%24.9%24.9% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial healthnot known
- –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (esef), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from RaySearch Laboratories AB (publ)'s statements, beside the median of Healthcare Information Services.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 21.7% | -7.1% | |
| Net margin | 16.9% | -6.8% | |
| Return on equity | 24.9% | -0.8% | |
| Revenue growth | 21.3% | 8.7% | |
| Free cash flow margin | 26.7% | 14.1% |
6of 6on the Piotroski tests of financial strength
RaySearch Laboratories AB (publ): financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in SEK millions; per-share figures in SEK; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,344+12.8%100% | 1,192+16.6%100% | 1,022+21.2%100% | 844+31.5%100% | 642−1.5%100% | 652—100% | |
| Cost of revenue | 102+2.4%7.6% | 100−6.6%8.3% | 107+12.2%10.4% | 95+88.5%11.3% | 50+16.2%7.9% | 43—6.7% | |
| Gross profit | 1,242+13.7%92.4% | 1,093+19.3%91.7% | 916+22.3%89.6% | 749+26.6%88.7% | 591−2.8%92.1% | 608—93.3% | |
| Research and development | 270+0.4%20.1% | 269+13.3%22.6% | 238−0.4%23.3% | 239+2.3%28.3% | 233+26.2%36.4% | 185—28.4% | |
| Selling and marketing | — | — | — | — | 300+3.1%46.8% | 291—44.7% | |
| General and administrative | 288+15.5%21.5% | 250+27.9%20.9% | 195+13.7%19.1% | 172+40.7%20.4% | 122+14.8%19.0% | 106—16.3% | |
| Operating income | 292+12.2%21.7% | 261+127%21.9% | 115+169%11.2% | 43—5.1% | −53—−8.3% | −3.5—−0.5% | |
| Interest and finance income | 7.1−37.7%0.5% | 11+132%1.0% | 4.9+342%0.5% | 1.1+56.6%0.1% | 0.7−74.1%0.1% | 2.7—0.4% | |
| Interest expense and finance costs | 12+28.9%0.9% | 9.0−7.2%0.8% | 9.7−15.5%0.9% | 11+90.0%1.4% | 6.0+5.1%0.9% | 5.7—0.9% | |
| Income before tax | 288+9.5%21.4% | 263+139%22.1% | 110+240%10.8% | 32—3.8% | −59—−9.1% | −6.5—−1.0% | |
| Income tax | 60+1.0%4.5% | 59+108%5.0% | 29+232%2.8% | 8.6—1.0% | −11−537%−1.8% | 2.6—0.4% | |
| Net income including minority interests | 228+11.9%16.9% | 204+149%17.1% | 82+243%8.0% | 24—2.8% | −47—−7.4% | −9.1—−1.4% | |
| Earnings per share, basic | 6.65+12.0%— | 5.94+150%— | 2.38+245%— | 0.69—— | -138.00—— | -26.00—— | |
| Earnings per share, diluted | 6.65+12.0%— | 5.94+150%— | 2.38+245%— | 0.69—— | — | — | |
| Balance sheet | |||||||
| Cash and cash equivalents | 407−12.0%20.4% | 463+34.6%22.1% | 344+114%17.6% | 160+56.3%8.5% | 103−39.2%5.9% | 169—13.1% | |
| Receivables | 240−5.9%12.0% | 255+6.0%12.2% | 240−4.0%12.3% | 250+46.6%13.3% | 171+8.8%9.8% | 157—12.2% | |
| Inventory | 22+108%1.1% | 11+13.7%0.5% | 9.3−33.9%0.5% | 14−53.0%0.8% | 30+229%1.7% | 9.1—0.7% | |
| Current assets | 971−1.4%48.7% | 985+22.7%47.1% | 802+27.8%41.1% | 628+21.6%33.5% | 516−10.5%29.7% | 577—44.9% | |
| Property, plant and equipment | 63−9.6%3.2% | 70−21.8%3.4% | 90−17.7%4.6% | 109—5.8% | — | — | |
| Right-of-use (leased) assets | 384−15.9%19.3% | 457−8.8%21.8% | 501−7.3%25.6% | 540+0.0%28.8% | 540+482%31.1% | 93—7.2% | |
| Other intangible assets | 5.6−20.0%0.3% | 7.0+5934%0.3% | 0.1−66.1%0.0% | 0.3—0.0% | — | — | |
| Non-current assets | 1,021−7.7%51.3% | 1,106−3.8%52.9% | 1,150−7.8%58.9% | 1,248+2.1%66.5% | 1,223+72.8%70.3% | 708—55.1% | |
| Total assets | 1,992−4.7%100% | 2,091+7.1%100% | 1,953+4.1%100% | 1,876+7.9%100% | 1,739+35.3%100% | 1,285—100% | |
| Accounts payable | — | — | — | — | 49+146%2.8% | 20—1.5% | |
| Current liabilities | 570−19.0%28.6% | 704+4.3%33.7% | 675+6.0%34.6% | 637+30.0%34.0% | 490+14.5%28.2% | 428—33.3% | |
| Lease liabilities (non-current) | 317−19.7%15.9% | 395−8.6%18.9% | 432−8.9%22.1% | 474—25.3% | — | — | |
| Non-current liabilities | 437−14.5%21.9% | 511−5.8%24.4% | 542−6.8%27.8% | 582−3.0%31.0% | 600+269%34.5% | 163—12.6% | |
| Total liabilities | 1,007−17.1%50.5% | 1,215−0.2%58.1% | 1,217−0.1%62.3% | 1,219+11.8%65.0% | 1,090+84.5%62.7% | 591—46.0% | |
| Retained earnings | 982+14.6%49.3% | 857+18.7%41.0% | 722+12.7%37.0% | 640+0.4%34.1% | 638−6.9%36.7% | 685—53.3% | |
| Shareholders' equity | 985+12.4%49.5% | 877+19.2%41.9% | 735+11.9%37.7% | 657+1.2%35.0% | 649−6.5%37.3% | 694—54.0% | |
| Total equity | 985+12.4%49.5% | 877+19.2%41.9% | 735+11.9%37.7% | 657+1.2%35.0% | 649−6.5%37.3% | 694—54.0% | |
| Total liabilities and equity | 1,992−4.7%100% | 2,091+7.1%100% | 1,953+4.1%100% | 1,876+7.9%100% | 1,739+35.3%100% | 1,285—100% | |
| Cash-flow statement | |||||||
| Depreciation and amortization | — | — | — | — | 0.1+7.8%0.0% | 0.1—0.0% | |
| Cash from operating activities | 387−20.2%28.8% | 485+6.4%40.7% | 456+42.2%44.6% | 321+34.6%38.0% | 238−28.2%37.1% | 332—50.9% | |
| Capital expenditure | −28—−2.1% | −13—−1.1% | −24—−2.4% | −13—−1.6% | −52—−8.1% | −30—−4.6% | |
| Intangible assets bought | 0—0.0% | −7.0—−0.6% | — | — | −203—−31.7% | −196—−30.1% | |
| Cash from investing activities | −228—−17.0% | −218—−18.2% | −209—−20.5% | −201—−23.9% | −238—−37.0% | −226—−34.6% | |
| Debt repaid | — | — | — | — | −50—−7.7% | 0—0.0% | |
| Dividends paid | −103—−7.6% | −69—−5.8% | — | — | — | — | |
| Cash from financing activities | −180—−13.4% | −160—−13.4% | −56—−5.5% | −72—−8.6% | −72—−11.3% | −44—−6.8% | |
| Exchange-rate effect on cash | −35−411%−2.6% | 11—0.9% | −6.8−162%−0.7% | 11+99.4%1.3% | 5.5—0.9% | −7.0—−1.1% | |
| Report | ESEF | ESEF | ESEF | ESEF | ESEF | ESEF | |
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
How RaySearch Laboratories AB (publ) compares in Healthcare Information Services
- Revenue$137 M · higher than 30% of 70
- Net margin16.9% · higher than 88% of 68
- Revenue growth21.3% · higher than 89% of 38
- 🇯🇵 EM Systems Co., Ltd.$128 M
- 🇺🇸 CareCloud, Inc.$87 M
- 🇯🇵 JMDC Inc.$1.4 B
- 🇬🇧 Craneware plc$1.0 B
- 🇺🇸 OptimizeRx Corporation$165 M
- 🇦🇺 Pro Medicus Limited$14.4 B
Peer comparison · Healthcare Information Services
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| RaySearch Laboratories AB (publ)🇸🇪 | $300 M | — | 16.9% | +21.3% |
| Veeva Systems Inc.🇺🇸 | $50.2 B | 49.5× | 29.4% | +16.3% |
| Pro Medicus Limited🇦🇺 | $14.4 B | 81.3× | — | — |
| 10x Genomics, Inc.🇺🇸 | $9.4 B | — | -10.8% | +5.3% |
| HealthEquity, Inc.🇺🇸 | $8.3 B | 35.3× | 17.4% | +9.5% |
| M3, Inc.🇯🇵 | $7.1 B | 21.5× | 14.0% | — |
| Doximity, Inc.🇺🇸 | $5.5 B | 39.5× | 21.1% | +13.1% |
| Privia Health Group, Inc.🇺🇸 | $2.8 B | 80.9× | 1.4% | +22.3% |
| Winning Health Technology Group Co., Ltd.🇨🇳 | $2.3 B | 41.3× | 13.8% | — |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Veeva Systems Inc.$50.2 B
- Pro Medicus Limited$14.4 B
- 10x Genomics, Inc.$9.4 B
- HealthEquity, Inc.$8.3 B
- M3, Inc.$7.1 B
- Doximity, Inc.$5.5 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 15, 2026
Figures from Official annual report (ESEF), value.today research, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at RaySearch Laboratories AB (publ)? Verify and update this profile — free
Show RaySearch Laboratories AB (publ)'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.